View in EDS

Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082].

Saved in:
Bibliographic Details
Title: Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082].
Authors: Cline EN; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA. Electronic address: ecline@acumenpharm.com., Antwi-Berko D; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Amsterdam, the Netherlands., Sundell K; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Johnson E; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Hyland M; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Zhang H; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Vanderstichele H; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Kaplow J; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Dean RA; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Stoops E; ADx NeuroSciences, Technologiepark 6, Gent, Belgium., Vanmechelen E; ADx NeuroSciences, Technologiepark 6, Gent, Belgium., Koel-Simmelink MJA; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Amsterdam, the Netherlands., Teunissen CE; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Amsterdam, the Netherlands., Sethuraman G; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Feaster T; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Siemers E; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA., Jerecic J; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.
Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2025 Aug; Vol. 12 (7), pp. 100217. Date of Electronic Publication: 2025 Jun 06.
Publication Type: Published Erratum
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40480947
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082].
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cline+EN%22">Cline EN</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA. Electronic address: ecline@acumenpharm.com.<br /><searchLink fieldCode="AU" term="%22Antwi-Berko+D%22">Antwi-Berko D</searchLink>; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Sundell+K%22">Sundell K</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+E%22">Johnson E</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Hyland+M%22">Hyland M</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Vanderstichele+H%22">Vanderstichele H</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Kaplow+J%22">Kaplow J</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Dean+RA%22">Dean RA</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Stoops+E%22">Stoops E</searchLink>; ADx NeuroSciences, Technologiepark 6, Gent, Belgium.<br /><searchLink fieldCode="AU" term="%22Vanmechelen+E%22">Vanmechelen E</searchLink>; ADx NeuroSciences, Technologiepark 6, Gent, Belgium.<br /><searchLink fieldCode="AU" term="%22Koel-Simmelink+MJA%22">Koel-Simmelink MJA</searchLink>; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Teunissen+CE%22">Teunissen CE</searchLink>; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam UMC, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Sethuraman+G%22">Sethuraman G</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Feaster+T%22">Feaster T</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Siemers+E%22">Siemers E</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.<br /><searchLink fieldCode="AU" term="%22Jerecic+J%22">Jerecic J</searchLink>; Acumen Pharmaceuticals, Inc, 1210-1220 Washington St., Suite 210, Newton, MA 02465, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101638820%22">The journal of prevention of Alzheimer's disease</searchLink> [J Prev Alzheimers Dis] 2025 Aug; Vol. 12 (7), pp. 100217. <i>Date of Electronic Publication: </i>2025 Jun 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101638820 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2426-0266 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222745807%22">22745807 </searchLink><i>NLM ISO Abbreviation: </i>J Prev Alzheimers Dis <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40480947
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.tjpad.2025.100217
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100217
    Titles:
      – TitleFull: Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cline EN
      – PersonEntity:
          Name:
            NameFull: Antwi-Berko D
      – PersonEntity:
          Name:
            NameFull: Sundell K
      – PersonEntity:
          Name:
            NameFull: Johnson E
      – PersonEntity:
          Name:
            NameFull: Hyland M
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Vanderstichele H
      – PersonEntity:
          Name:
            NameFull: Kaplow J
      – PersonEntity:
          Name:
            NameFull: Dean RA
      – PersonEntity:
          Name:
            NameFull: Stoops E
      – PersonEntity:
          Name:
            NameFull: Vanmechelen E
      – PersonEntity:
          Name:
            NameFull: Koel-Simmelink MJA
      – PersonEntity:
          Name:
            NameFull: Teunissen CE
      – PersonEntity:
          Name:
            NameFull: Sethuraman G
      – PersonEntity:
          Name:
            NameFull: Feaster T
      – PersonEntity:
          Name:
            NameFull: Siemers E
      – PersonEntity:
          Name:
            NameFull: Jerecic J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2426-0266
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The journal of prevention of Alzheimer's disease
              Type: main
ResultId 1